Invest in Takezo LLC: DNA-Informed Ready-to-Eat Precision Supplements. Disrupting a $67B market!

Reid A Block

Co-founder / CEO

Conceptualized, developed, and exited the nations first private off-road motorsports adventure park called Paragon Adventure Park. Strategy attainment and performance management expert, providing services to enterprise & healthcare clients.

Andrew K. Johnston

Co-founder / COO

Seasoned business operator. Prior to co-founding Takezo LLC, 15 yrs. building boutique consulting practice to high-growth/closely held companies. MBA with finance and supply chain acumen honed from 12 yrs. with Exxon, Agrium, Esco and Deloitte.

Jim Cali

Advisor

Led Cadbury’s $5B global gum and candy category growing +9% CAGR, improving EBITDA and gaining + 6pts of global market share vs Wrigley. Launched new brands / innovation platforms which generated revenue between $150m and $400M each.

Investor Q&A

Expand all

What does your company do?

Takezo applies integrated technology to translate consumer-provided data into ready-to-eat supplements, designed to help our consumers perform at their best. Takezo uses artificial intelligence and optional consumer DNA data to collect health and lifestyle information. Takezo then formulates supplement products customized for each consumer. Takezo delivers directly to consumers via the convenience of a monthly subscription. Our consumers can change their precision formulation at any time.

Where will your company be in 5 years?

We want to be the #1 provider of personalized precision nutritional solutions in the world.

Why did you choose this idea?

We were looking for premium functional supplements that would suit our unique needs, and provide specific functional benefits. We also have had our DNA run and participated in the Predict Studies, and the reports showed genetic deficiencies in vitamins and minerals. We found few commercially available solutions. Thus Takezo was launched.

How quickly can you be in the market?

Our DNA reports will be the first to release and in an almost immediate fashion. Consumable products face a critical-path constraint of extended lead times related to packaging producers of 10-14 weeks. The balance of our production lead times each fall within this timeframe.

How far along are you?

We have spent the past 18 months building our internal capabilities and partnering with some of the leading industry service providers including The Intertwine Group, Propeller Industries, AgroPur, REDWOOD to name a few. We have our end to supply chain, sales enabling technology, 360 marketing plans, go to market formulations, packaging, and a phenomenal leadership team, Board of Directors, and team of advisors. I like to paint the picture of we have the jets on the runway, and are awaiting the orders from our investors to launch.

Does Takezo have a plan for growing beyond the current product offering?

From a future development point of view, we have identified opportunities to customize the existing functional drink mixes as well as a customizable, nutrient-dense meal replacement ready to mix powder. We will also be paying attention to the customization our consumers make, taking note of any trends that may guide the launch of a standardized product based on those formulations. This will allow Takezo to expand market distribution and awareness while profiting from the lower costs of goods sold afforded by standardized production.

Who made the introduction video?

100% of the video and editing was done with internal Takezo stakeholders.

How do we contact you to learn more?

You can email us @ Hi@takezo86k.com You can book a meeting with us @: https://outlook.office365.com/owa/calendar/Takezo@takezo86k.com/bookings/

What does your financial model show?

Our 5 year proforma business plan projects Takezo to build a net loyal subscriber base in excess of 58K and combined subscriber and single order revenues cresting $40 million annually. Our proforma unit economics are stellar showing an average order value of $70, at an average gross margin of 70%. We expect to have net positive cash flow and profit by the end of year 2. Our current revenue capture plan shows Customer Acquisition Cost (CAC) hovering around $45 per customer resulting in an estimated median Lifetime Value (LTV) of $195; LTV:CAC ratio of about 4:1.

Tell me about the market Takezo is targeting.

The Takezo team has identified a large segment of the US total supplement and functional markets, zeroing in on a target population representing $67B market with an average CAGR of 7.86%. Supporting our market identification is information from New Hope Network indicating that 77% of the US adult population take dietary supplements and, poignantly, 68% of the unemployed continue to take supplements. We have identified a large target population of consumers. Our core consumer likes to plant flags, whether it is training to finish that charity bike ride/run/walk, lower their handicap, excel at their e-sport game(s), achieve that next level in training, or even setting a goal to win the Spartan Race Global Championships, Takezo is on that journey with each consumer.

How did you arrive at personalized Supplements as a business model?

Through the shared experiences of our founders, we identified significant opportunities in the personal performance & wellness category, including personalized (ready to eat) daily supplements, premium functional drink mixes, genomic and metabolic reporting, and other personal performance technology. Digging deeper into the industry, we recognized over $600 million that had recently been invested in companies providing at-home DNA and Microbiome testing. MIT Technology (Link in Downloads section) predicts that by 2022, 100 million people will have their DNA data. Additionally, advancements in wearables, trackers, and at-home testing technology have encouraged the release of over 165k technology apps designed to leverage the personal performance data and provide a variety of targeted services. Absent in the development ecosystem was an initiative to integrate data technology, nutrition science, and advanced manufacturing to generate aligned nutrition products in support of an individual's personal objectives. The founders of Takezo determined to address this gap, and by doing so, position the company in a global personalized nutrition & wellness market, currently projected to reach $130 billion over the next five years. One of our founders (Reid) used one of the recently developed technology service offerings to look at his specific nutrigenetics (how genes influence the utilization of nutrients and bioactive compounds), based on his 23&Me™ DNA results, and this is some of what he discovered using the Takezo GeneLytics engine (image below): Armed with this information, Reid sought out supplements that would help him fix his specific supplement gaps. His search for solutions to help him personalize his supplement regimen didn't yield many results outside of those requiring too many pills to swallow. In addition to learning what gaps needed to be filled, Reid also learned that supplementing with Vitamin E could likely be harmful to his overall health. Personalized nutrition was going to mean developing solutions for what consumers need and for what they don't need.

This appears to involve complex technology.

Our approach to this vast market opportunity leverages artificial intelligence, machine learning, and advanced/robotic food manufacturing systems. These solutions while seeming complex, come naturally to many on the Takezo team. With these complexities, also comes a barrier to entry by others interested in competing directly with Takezo on all fronts. Our technology solutions focus on easing the friction for the consumer while minimizing the operational complexities for Takezo. An example is the bot that we trained for the convenience of the consumer. This bot guides a consumer through a 3-minute Q&A that helps us identify some potential nutritional gaps, leading to a "first-pass" at a personalized product. The bot presents a choice allowing the consumer to purchase the configured product or to continue on the interview, resulting in a more customized product. For our consumer, more customized = a better match with their needs and a more fulfilling experience. For Takezo this not only results in better consumer satisfaction but also in a much closer and longer-lasting relationship with that consumer by building in higher switching costs.

How does Takezo plan to find their consumers and build revenue?

Our marketing strategy is well-traveled and proven by the most successful direct brands. We plan on attracting and retaining our consumers with a modern 360-degree marketing plan, that will be managed in house and executed by partners in performance marketing. In addition to paid media, our approach will include editorial, consumer submitted & original content, event participation/sampling/activation (Spartan Race partnerships), and earned media/PR. Takezō has engaged some of the leading performance marketing resources to help up us win the hearts, minds, and the share of stomach of our consumers. We are deploying an Omnichannel Revenue Generation model, that will enable direct to consumer and retail options for the convenience of our consumers. We strive to normalize pricing across our channels, as well as provide value & products exclusive to each revenue channel. Takezo has entered into an agreement with the 3rd largest (globally) sports nutrition e-tailor and will onboard with this customer 2-4 weeks after funding.

Why Takezo? What does it mean?

Takezō was born Miyamoto Musashi during Japan’s Edo period (1603-1868) and was to become the greatest swordsman of the period. Musashi was what today we may call a problem child. He was a self-trained sword fighter who won his first duel at the age of 13 by killing a renown Samurai. Musashi spent much of his life traveling (wandering) throughout Japan, challenging Samurai warriors to duels in an effort to prove himself. Overall, he won sixty duels in his life, some against multiple enemies. Musashi is credited as the founder of the Niten-ryū style of swordsmanship and the author of ‘The Book of Five Rings’, a book on strategy, tactics, and philosophy that is still widely read and referred to today. Ultimately Musashi recognized later in his life, through training others and his writing, that his greatest mark on the world would be the “masters” he created rather than the number he destroyed. We Believe that a measure of greatness is the number of 'masters' that one has left behind, and not just what the individual has achieved by themselves.

What are Takezo's Values?

OUR CORE VALUES • Know the Way • Be deliberate • Know what success looks like • Pay attention to the details • Never compromise quality • Push the limits with your experiences: Fail Fast, Fail Forward • Take ownership and get it done • Know when to lead & when to follow • Be curious, innovate, and constantly improve • Build Trust: Be authentic, transparent, and operate with integrity • Challenge yourself, the team, and process, in the pursuit of excellence • Listen, communicate, collaborate, & build high performing teams focused on the mission and strategy • Be passionate, courageous, and make a positive impact • Inspire passion, adventure, and have fun

What will the money be used for?

○ Technology ○ Marketing | Revenue ○ Operations Funds will be directed towards: • Development/production of AI/Machine Learning Technology • Manufacturing Technology Integration • Equip™ launch • Attract/Retain Key Resources

1	Pent up Consumer Demand! Consumers seek personalized nutrition and an edge from their DNA data.
2	Subscription sales model = Revenue predictability, more consumer Engagement, greater Margins
3	COVID-19-fueled hyper-growth of online supplement spend expected to accelerate during fall/winter.
4	Customizable EQUIP™ supplement and DNA-informed GeneLytics™ Nutrigenomics Reports ✔ Market-Ready.
5	The global Personalized Nutrition and Wellness Market set to reach $130B in five years.
6	The supplement industry e-comm. growth rate has skyrocketed; expected to grow by 61.4% in 2020.
7	Non-pill formats now account for 52% of supplement sales across all channels.
8	Diverse \| Experienced Leadership Team. Exceptional credentials: CPG, D2C, subscription, Marketing

1	Future Funding. Takezo LLC may never receive a future equity financing or elect to convert the Securities upon such future financing. In addition, the Company may never undergo a liquidity event such as a sale of the Company or an IPO. If neither the conversion of the Securities nor a liquidity event occurs, the Purchasers could be left holding the Securities in perpetuity. The Securities have numerous transfer restrictions and will likely be highly illiquid, with no secondary market on which to sell them. The Securities are not equity interests, have no ownership rights, have no rights to the Company’s assets or profits and have no voting rights or ability to direct the Company or its actions.
2	We are a Start-up company without prior revenues or sales. Our business model, including sales and growth forecasts are unproven. While the model assumptions are informed by the considerable business experience of our management team and industry advisors, actual results will likely be different from those predicted by the model. Our financial results will differ from those forecasted and any valuation of Takezo LLC at this stage is difficult to assess.
3	Small management team. We rely on a small management team to execute the business plan. In the event of a loss of a team member, the company may have difficulty achieving its business objectives. Additionally, we have no assurance of being able to attract and retain the personnel and skills required to grow the business as planned.
4	Supply chain risks. Takezo depends on a network of manufacturing/co-packer and fulfillment organizations to execute our business. The inability of any of these partner organizations to follow through on their commitment would require us to replace them with another partner. As a nutrition business, we carry certain food safety risks. We rely on the practices and certifications maintained by our supply chain partners to mitigate these safety risks.
5	Use of proceeds in this offering. Our management is entrusted to make decisions in the best interest of the company. That includes using their discretion when applying the proceeds of this offering to our operations. While we state our intended uses of funds, changes in circumstances, both economic and operational, and the development of new opportunities could cause the management team to make changes to the stated uses of funds disclosed in this offering.
6	We are a food company. As a food and supplement company we face certain risks related to both food safety and regulatory practices throughout our supply chain. We mitigate these risks to the business through management vigilance and peerless legal and risk management advisor firms. Importantly, we seek to protect our consumers by partnering with recognized, certified and equally minded supply chain partner firms. Additionally, as a food company we face unforeseen risk associated with unknown and unpredictable use of product by the consumer.
7	These are not all the risks. We have highlighted here what we as the management team see as the main risks related to this offering. This is not a comprehensive list of all risks. For more risks associated with this offering, see the Offering Document and see the Wefunder FAQ page at https://help.wefunder.com/
8	Kim Terry, Patrick Connors, Bryan Emmerson and Karen Vaughn are part-time officers. As such, it is likely that the company will not make the same progress as it would if that were not the case.

Director	Occupation	Joined
Karen Vaughn	Senior Director, North America Consumer Services @ Nike Inc.	2018
Bryan Emmerson	CIO @ Pacific Seafood	2018
Gregory Montanaro	Honorary Consul @ Austrian Consulate in Philadelphia	2020
Christopher Topolewski	Managing Member @ WIck Capital Partners LLC	2018
Andrew K. Johnston	COO @ Takezo LLC	2018
Reid A. Block	CEO @ Takezo LLC	2018

Officer	Title	Joined
Kim Terry	CIO	2019
Patrick Connors	CRO	2018
Andrew K. Johnston	COO	2018
Reid A. Block	CEO	2018

Holder	Securities Held	Voting Power
1859RB, LLC	3,220,000 Common Units	29.3%
Wick Management, LLC	2,220,000 Common Units	20.2%

Invest in Takezo LLC

DNA-Informed Ready-to-Eat Precision Supplements. Disrupting a $67B market!

Invest in Takezo LLC

DNA-Informed Ready-to-Eat Precision Supplements. Disrupting a $67B market!

$17,150

15

Invest via a

Invest via a

Why you may want to invest in us...

Why investors us

we've raised $17,150 since our founding

Our team

And Our Major Accomplishments

In the news

Downloads

The Future of Personalized Supplements & Nutrition is Here!

Introducing EQUIP™

Genelytics™ helps untangle that DNA report

Our Opportunity

The Takezo Solution

OurStory

Not stopping there…

Investor Q&A

Financials

At a Glance

Risks

Details

The Board of Directors

Officers

Voting Power

Past Equity Fundraises

Outstanding Debts

Related Party Transactions

Use of Funds

Capital Structure

The Funding Portal

Form C Filing on EDGAR

Ask a Question

Signup

$50,000	60% Business development & revenue generation in the form of market research and direct advertising program and a launch of sales for our DNA-based health and nutrition reports, and pre-sales of Takezō Focus. 25% Technology platform development in the form of initial system integration programming to enable launch of Takezo Equip. 8.5% Business operations. 6.5% WeFunder fee.
$350,000	40% Brand development marketing and direct advertising to launch and grow sales of first personalized FIT product and purchase inventory for Focus sales launch & pre-ordered product fulfillment. 40% Technology platform development further bot development, implement CRM, ERP and fulfillment systems. 13.5% Business operations and talent acquisition. 6.5% WeFunder fee.
$750,000	36% Further Brand development marketing and direct advertising to grow subscription sales of Equip FIT and purchase inventory to expand Functional product line sales with Energy and Rest sales launch. 48% Expanded build-out of technology platform to enhance machine learning and AI capability. 9.5% Business operations and talent acquisition. 6.5% WeFunder fee.

Invest via a

Why you may want to invest in us...

Why investors us

we've raised $17,150 since our founding

Our team

And Our Major Accomplishments

In the news

Downloads

The Future of Personalized Supplements & Nutrition is Here!

Introducing EQUIP™

Genelytics™ helps untangle that DNA report

Our Opportunity

The Takezo Solution

OurStory

Not stopping there…

Investor Q&A

Financials

At a Glance

Risks

Details

The Board of Directors

Officers

Voting Power

Past Equity Fundraises

Outstanding Debts

Related Party Transactions

Use of Funds

Capital Structure

The Funding Portal

Form C Filing on EDGAR

Ask a Question

Your commitment was sent

Signup

Forgot password?